180 related articles for article (PubMed ID: 37233480)
1. Loop2 Size Modification Reveals Significant Impacts on the Potency of α-Conotoxin TxID.
Dong J; Zhang P; Xie J; Xie T; Zhu X; Zhangsun D; Yu J; Luo S
Mar Drugs; 2023 May; 21(5):. PubMed ID: 37233480
[TBL] [Abstract][Full Text] [Related]
2. Fluorescently Labeled α-Conotoxin TxID, a New Probe for α3β4 Neuronal Nicotinic Acetylcholine Receptors.
Huang M; Zhu X; Yang Y; Tan Y; Luo S; Zhangsun D
Mar Drugs; 2022 Aug; 20(8):. PubMed ID: 36005514
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel α-conotoxin TxID from Conus textile that potently blocks rat α3β4 nicotinic acetylcholine receptors.
Luo S; Zhangsun D; Zhu X; Wu Y; Hu Y; Christensen S; Harvey PJ; Akcan M; Craik DJ; McIntosh JM
J Med Chem; 2013 Dec; 56(23):9655-63. PubMed ID: 24200193
[TBL] [Abstract][Full Text] [Related]
4. Effect of Methionine Oxidation and Substitution of α-Conotoxin TxID on α3β4 Nicotinic Acetylcholine Receptor.
Ren J; Li R; Ning J; Zhu X; Zhangsun D; Wu Y; Luo S
Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29925760
[TBL] [Abstract][Full Text] [Related]
5. α-Conotoxin [S9A]TxID Potently Discriminates between α3β4 and α6/α3β4 Nicotinic Acetylcholine Receptors.
Wu Y; Zhangsun D; Zhu X; Kaas Q; Zhangsun M; Harvey PJ; Craik DJ; McIntosh JM; Luo S
J Med Chem; 2017 Jul; 60(13):5826-5833. PubMed ID: 28603989
[TBL] [Abstract][Full Text] [Related]
6. Single Amino Acid Substitution in α-Conotoxin TxID Reveals a Specific α3β4 Nicotinic Acetylcholine Receptor Antagonist.
Yu J; Zhu X; Harvey PJ; Kaas Q; Zhangsun D; Craik DJ; Luo S
J Med Chem; 2018 Oct; 61(20):9256-9265. PubMed ID: 30252466
[TBL] [Abstract][Full Text] [Related]
7. α-Conotoxin TxID and [S9K]TxID, α3β4 nAChR Antagonists, Attenuate Expression and Reinstatement of Nicotine-Induced Conditioned Place Preference in Mice.
Li X; You S; Xiong J; Qiao Y; Yu J; Zhangsun D; Luo S
Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33339145
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of disulfide-rich cyclic α-conotoxin [S9A]TxID analogues as novel α3β4 nAChR antagonists.
Wang S; Ren J; Li R; Li X; Zhangsun D; Wu Y; Luo S
Bioorg Chem; 2021 Jul; 112():104875. PubMed ID: 33823404
[TBL] [Abstract][Full Text] [Related]
9. α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.
van Hout M; Valdes A; Christensen SB; Tran PT; Watkins M; Gajewiak J; Jensen AA; Olivera BM; McIntosh JM
Neuropharmacology; 2019 Oct; 157():107691. PubMed ID: 31255696
[TBL] [Abstract][Full Text] [Related]
10. Alanine scan of α-conotoxin RegIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist.
Kompella SN; Hung A; Clark RJ; Marí F; Adams DJ
J Biol Chem; 2015 Jan; 290(2):1039-48. PubMed ID: 25411242
[TBL] [Abstract][Full Text] [Related]
11. Structural and Functional Characterization of a Novel α-Conotoxin Mr1.7 from Conus marmoreus Targeting Neuronal nAChR α3β2, α9α10 and α6/α3β2β3 Subtypes.
Wang S; Zhao C; Liu Z; Wang X; Liu N; Du W; Dai Q
Mar Drugs; 2015 May; 13(6):3259-75. PubMed ID: 26023835
[TBL] [Abstract][Full Text] [Related]
12. Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins.
Cuny H; Kompella SN; Tae HS; Yu R; Adams DJ
J Biol Chem; 2016 Nov; 291(45):23779-23792. PubMed ID: 27646000
[TBL] [Abstract][Full Text] [Related]
13. Alanine-Scanning Mutagenesis of α-Conotoxin GI Reveals the Residues Crucial for Activity at the Muscle Acetylcholine Receptor.
Ning J; Li R; Ren J; Zhangsun D; Zhu X; Wu Y; Luo S
Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30551685
[TBL] [Abstract][Full Text] [Related]
14. α-Conotoxin Bt1.8 from Conus betulinus selectively inhibits α6/α3β2β3 and α3β2 nicotinic acetylcholine receptor subtypes.
Ning H; Huang B; Tae HS; Liu Z; Yu S; Li L; Zhang L; Adams DJ; Guo C; Dai Q
J Neurochem; 2021 Oct; 159(1):90-100. PubMed ID: 34008858
[TBL] [Abstract][Full Text] [Related]
15. Molecular Determinants of Species Specificity of α-Conotoxin TxIB towards Rat and Human α6/α3β4 Nicotinic Acetylcholine Receptors.
Xie T; Qin Y; Zhao J; Dong J; Qi P; Zhang P; Zhangsun D; Zhu X; Yu J; Luo S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239959
[TBL] [Abstract][Full Text] [Related]
16. A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors.
Luo S; Zhangsun D; Schroeder CI; Zhu X; Hu Y; Wu Y; Weltzin MM; Eberhard S; Kaas Q; Craik DJ; McIntosh JM; Whiteaker P
FASEB J; 2014 Apr; 28(4):1842-53. PubMed ID: 24398291
[TBL] [Abstract][Full Text] [Related]
17. Degradation kinetics of α-conotoxin TxID.
Xu P; Xiong Y; Liu Y; Yu S; Zhangsun D; Wu Y; Luo S
FEBS Open Bio; 2019 Sep; 9(9):1561-1572. PubMed ID: 31278882
[TBL] [Abstract][Full Text] [Related]
18. The 3/4- and 3/6-Subfamily Variants of α-Conotoxins GI and MI Exhibit Potent Inhibitory Activity against Muscular Nicotinic Acetylcholine Receptors.
Ma X; Huang Q; Yu S; Xu S; Huang Y; Zhao Z; Xiao X; Dai Q
Mar Drugs; 2021 Dec; 19(12):. PubMed ID: 34940704
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an α 4/7-Conotoxin LvIF from
Guo M; Yu J; Zhu X; Zhangsun D; Luo S
Mar Drugs; 2021 Jul; 19(7):. PubMed ID: 34356823
[TBL] [Abstract][Full Text] [Related]
20. DSPE-PEG Modification of α-Conotoxin TxID.
Zhao W; Xiong Y; Zhangsun D; Luo S
Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31181805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
